MEGAN BAUDER: Open Payments
NPI 1619645439 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 12 payments from 7 companies in 2025. Trend: 2023 $19 · 2024 $312 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| ABBVIE INC. | 3 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $19 |
| Amgen Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
Products named: AIRSUPRA, VRAYLAR, Kerendia, FREESTYLE LIBRE 3, OTEZLA, QULIPTA, SHINGRIX, ZENPEP.
Industry payments across AZ — which companies pay providers there.
